top of page
Gilboa Therapeutics is delighted to welcome Barry Labinger as CEO
Barry Labinger brings more than 30 years of experience in leadership roles in the biopharmaceutical industry, including both public and private companies.
We look forward to a successful journey together!
June 15, 2022
December 19, 2022
Gilboa Therapeutics has been recognized as one of the 33 healthcare and biotech start-ups investors expect to take off in 2023
Gilboa Therapeutics has been recognized by Insider Business as one of the 33 healthcare and biotech start-ups investors expect to take off in 2023. We are grateful for the support of our investors and look forward to continuing to make progress in the development of our SolidT therapy.
We can't wait to see what the future holds for Gilboa Therapeutics!
Read the full article here.
bottom of page